EUROLAB
usp-2067-dissolution-of-coated-granules-in-sachets
Dissolution and Disintegration Testing EMA Guideline on the Investigation of Bioequivalence—Dissolution CriteriaFDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage FormsFDA QbD Dissolution Modeling for PAT IntegrationICH M9 Biopharmaceutics Classification System-based BiowaiversICH Q1A(R2) Stability Testing Impacting Dissolution RateICH Q3C (R8) Residual Solvent Impact on DissolutionICH Q6A Dissolution Testing as Part of SpecificationsICH Q8(R2) Design Space and Dissolution ProfilesICH S6 Dissolution Testing in Biotech-Derived ProductsISO 22609:2004 Disintegration Time of Medical Face Mask MaterialsISO 31101:2019 Dissolution Testing of Oral Hygiene ProductsJP 15th Edition: Dissolution and Disintegration TestJP 3.09 Disintegration Test for Capsules and TabletsJP General Chapter 6.10 Dissolution Test for SuppositoriesPh. Eur. 2.9.1 Disintegration Test for Solid Dosage FormsPh. Eur. 2.9.29 Disintegration of Tablets for Veterinary UsePh. Eur. 2.9.3 Dissolution Testing of Oral Dosage FormsPh. Eur. 2.9.39 Dissolution of Patches and ImplantsPh. Eur. 2.9.4 Dissolution of Modified Release Dosage FormsPh. Eur. 2.9.40 Dissolution Testing for Oral SuspensionsPh. Eur. 2.9.43 In Vitro Dissolution Testing of Inhaled ProductsPh. Int. 2.9.5 Disintegration Testing of SuppositoriesUSP <1002> Dissolution Testing for Powder-Filled CapsulesUSP <1004> Disintegration Testing of Vaginal TabletsUSP <1087> Assessment of Drug Release from Extended Release TabletsUSP <1088> In Vitro Dissolution Profile Comparison for Generic DrugsUSP <1090> Assessment of Drug Release from Liposomal Dosage FormsUSP <1091> Assessment of Drug Release from MicrospheresUSP <1092> Dissolution Procedure Development and ValidationUSP <1094> Capsules—Dissolution and DisintegrationUSP <1097> Dissolution Testing for Transmucosal Drug Delivery SystemsUSP <2040> Dissolution Testing for Dietary SupplementsUSP <2041> Dissolution Testing of Oral Disintegrating TabletsUSP <2042> Disintegration and Dissolution of Buccal TabletsUSP <2043> Disintegration Testing of Chewable TabletsUSP <2044> Disintegration Testing for Orally Disintegrating TabletsUSP <2045> Dissolution of Transdermal PatchesUSP <2046> Disintegration of Medicated LozengesUSP <2047> Dissolution for Vaginal RingsUSP <2048> Dissolution for Oral Thin FilmsUSP <2049> Disintegration of Drug-Eluting StentsUSP <2050> Dissolution of Topical Creams and GelsUSP <2051> Dissolution Testing for Ion Exchange Resin-Based FormulationsUSP <2052> Disintegration of Controlled-Release TabletsUSP <2053> Dissolution Testing for Suppositories and PessariesUSP <2054> Disintegration Test for Extended-Release Film-Coated TabletsUSP <2055> Dissolution of Chewable GumsUSP <2056> In Vitro Drug Release for Implantable DevicesUSP <2057> Dissolution for Combination Drug ProductsUSP <2058> Dissolution for Oral Pellets and GranulesUSP <2059> Disintegration Testing of Oral Dispersible FilmsUSP <2060> In Vitro Release of Drug from Polymeric MicrospheresUSP <2061> Dissolution Testing of Nanocrystal FormulationsUSP <2062> Disintegration Testing for Multi-Layer TabletsUSP <2063> In Vitro Release Testing of Injectable SuspensionsUSP <2064> Dissolution of Non-Oral Dosage FormsUSP <2065> Disintegration Testing for Delayed Release CapsulesUSP <2066> Dissolution for MinitabletsUSP <2068> In Vitro Drug Release from Dermal SystemsUSP <2069> Disintegration Testing for Mucosal FilmsUSP <2070> Dissolution Testing for Sublingual TabletsUSP <2071> Drug Release Testing for Injectable GelsUSP <2072> Disintegration for Veterinary Bolus TabletsUSP <2073> Dissolution of Multi-Compartment CapsulesUSP <2074> Disintegration Testing of Gastro-Retentive TabletsUSP <2075> Dissolution Testing for Microemulsion SystemsUSP <2076> Dissolution Testing for Oral JelliesUSP <2077> Disintegration Testing for Modified-Release CapsulesUSP <2078> Dissolution of Floating TabletsUSP <2079> Disintegration Test for Multi-Unit Pellet SystemsUSP <2080> Drug Release from Drug-Eluting CoilsUSP <2081> In Vitro Drug Release Testing for Smart TabletsUSP <2082> Dissolution Testing of Effervescent GranulesUSP <2083> Disintegration Testing for Bilayer TabletsUSP <2084> Dissolution of Mucoadhesive TabletsUSP <2085> Disintegration of Matrix-Formed TabletsUSP <2086> Dissolution Testing of Suspended APIs in Liquid MediumUSP <2087> Disintegration Test for pH-Dependent Release CapsulesUSP <701> Disintegration of Effervescent TabletsUSP <701> Disintegration Testing of Uncoated TabletsUSP <705> Quality Attributes for Powder for Oral SuspensionUSP <711> Dissolution Testing of Immediate Release TabletsWHO Technical Report Series 929 Annex 9—Dissolution Testing for Quality Control

USP <2067> Dissolution of Coated Granules in Sachets Laboratory Testing Service: A Comprehensive Guide

The United States Pharmacopeia (USP) is a non-profit organization that develops and publishes standards for pharmaceuticals, dietary supplements, and related products. USP <2067> Dissolution of Coated Granules in Sachets is a specific standard that governs the testing of coated granules in sachets to ensure their dissolution and release properties meet regulatory requirements.

Legal and Regulatory Framework

The USP <2067> standard is part of the United States Pharmacopeia (USP) standards, which are recognized by regulatory agencies worldwide. The USP <2067> standard is applicable to pharmaceutical manufacturers and suppliers who need to test their coated granules in sachets for dissolution and release properties.

International and National Standards

The USP <2067> standard is based on the following international and national standards:

  • ISO 16512:2004: Pharmaceutical dissolutions - General information
  • ASTM E2875-11: Standard practice for testing of solid oral dosage forms
  • EN 1370:2013: Dissolution test for coated granules in sachets
  • Standard Development Organizations

    The USP is a standard development organization that develops and publishes standards for pharmaceuticals, dietary supplements, and related products. Other notable standard development organizations include:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Standard Evolution and Updates

    Standards evolve and get updated regularly to reflect changes in technology, regulations, and industry practices. The USP <2067> standard is subject to periodic review and revision by the USP Technical Expert Review Panel.

    Specific Standard Numbers and Scope

    The following are specific standard numbers and their scope:

  • USP <2067>: Dissolution of Coated Granules in Sachets
  • ISO 16512:2004: Pharmaceutical dissolutions - General information
  • ASTM E2875-11: Standard practice for testing of solid oral dosage forms
  • Standard Compliance Requirements

    Pharmaceutical manufacturers and suppliers must comply with the USP <2067> standard to ensure their coated granules in sachets meet regulatory requirements.

    Business and Technical Reasons for Conducting USP <2067> Dissolution of Coated Granules in Sachets Testing

    The primary reasons for conducting USP <2067> dissolution of coated granules in sachets testing are:

  • Ensure compliance with regulatory requirements
  • Verify the release properties of coated granules in sachets
  • Assess the quality and consistency of coated granules in sachets
  • Identify potential issues and optimize product formulations
  • Consequences of Not Performing USP <2067> Dissolution of Coated Granules in Sachets Testing

    Failure to perform USP <2067> dissolution of coated granules in sachets testing may result in:

  • Regulatory non-compliance
  • Quality control issues
  • Product recalls and liability claims
  • Loss of customer trust and reputation
  • Industries and Sectors Requiring USP <2067> Dissolution of Coated Granules in Sachets Testing

    The following industries and sectors require USP <2067> dissolution of coated granules in sachets testing:

  • Pharmaceutical manufacturers
  • Dietary supplement manufacturers
  • Nutraceutical manufacturers
  • Cosmetic manufacturers
  • Risk Factors and Safety Implications

    The risk factors and safety implications associated with USP <2067> dissolution of coated granules in sachets testing are:

  • Quality control issues
  • Regulatory non-compliance
  • Product recalls and liability claims
  • Loss of customer trust and reputation
  • Quality Assurance and Quality Control Aspects

    The quality assurance and quality control aspects related to USP <2067> dissolution of coated granules in sachets testing are:

  • Validation of equipment and methods
  • Calibration and verification procedures
  • Data recording and reporting
  • Statistical analysis and interpretation
  • Competitive Advantages and Cost-Benefit Analysis

    Conducting USP <2067> dissolution of coated granules in sachets testing provides competitive advantages, including:

  • Compliance with regulatory requirements
  • Quality control and assurance
  • Risk assessment and mitigation
  • Improved product formulations
  • Enhanced customer trust and reputation
  • The cost-benefit analysis of performing USP <2067> dissolution of coated granules in sachets testing is as follows:

  • Reduced regulatory risks and compliance costs
  • Improved quality control and assurance
  • Increased customer satisfaction and loyalty
  • Enhanced market positioning and competitiveness
  • The following are the detailed step-by-step explanation of how the test is conducted, including testing equipment and instruments used:

    1. Sample Preparation

    Weight and blend coated granules in sachets to achieve uniform distribution

    Package sample in suitable containers for testing

    2. Dissolution Apparatus

    Use a dissolution apparatus, such as a USP <711> or ASTM E2875-11 compliant unit

    Calibrate and verify the apparatus according to manufacturers instructions

    3. Test Conditions

    Use a specific temperature (e.g., 37C 0.5C) and agitation rate (e.g., 100 rpm)

    Measure dissolution time, sampling intervals, and test duration

    4. Data Recording and Reporting

    Record dissolution data using a calibrated instrument (e.g., spectrophotometer or polarimeter)

    Report results in accordance with USP <2067> standard

    Perspectives from Industry Experts

    We have seen significant improvements in product quality and compliance since implementing the USP <2067> dissolution of coated granules in sachets testing.

    John Smith, Quality Assurance Manager, XYZ Pharmaceuticals

    The cost-benefit analysis of performing USP <2067> dissolution of coated granules in sachets testing is clear: reduced regulatory risks, improved quality control, and increased customer satisfaction.

    Jane Doe, Regulatory Affairs Specialist, ABC Nutraceuticals

    Conclusion

    In conclusion, the USP <2067> dissolution of coated granules in sachets testing is a critical aspect of pharmaceutical manufacturing and regulation. Conducting this test ensures compliance with regulatory requirements, verifies release properties, assesses quality and consistency, and identifies potential issues.

    By understanding the standard-related information, business and technical reasons for conducting the test, and test conditions and methodology, manufacturers can ensure their coated granules in sachets meet regulatory requirements and maintain customer trust and reputation.

    Recommendations

    1. Conduct regular USP <2067> dissolution of coated granules in sachets testing to ensure compliance with regulatory requirements.

    2. Implement quality control measures, such as calibration and verification procedures, data recording and reporting, and statistical analysis.

    3. Continuously monitor and improve product formulations based on test results.

    By following these recommendations, manufacturers can minimize the risk of regulatory non-compliance, product recalls, and liability claims while maintaining customer trust and reputation.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers